Showing results (1531-1540 of 2,271) with videos related to

Sort By:
Pageof 228
The Pediatric Infectious Disease Journal|December 18, 2023
Vaccine-preventable Pediatric Acute Bacterial Meningitis in France: A Time Series Analysis of a 19-Year Prospective National Surveillance NetworkAlexis Rybak, Naïm Ouldali, Emmanuelle Varon, et al.
Nutrients|March 12, 2022
Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference CentreAgnieszka Ochocińska, Marta Wysocka-Mincewicz, Artur Groszek, et al.
Scientific Reports|July 4, 2019
Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing LossSandeep Sheth, Kelly Sheehan, Asmita Dhukhwa, et al.
Progress in Brain Research|April 22, 2014
Effects of glycinergic inhibition failure on respiratory rhythm and pattern generationNatalia A Shevtsova, Dietrich Büsselberg, Yaroslav I Molkov, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 1, 2004
Ototoxicity of ototopical antibiotic drops in humansGreg Matz, Leonard Rybak, Peter S Roland, et al.
Mbio|April 4, 2019
Mutations in <i>hmg1</i>, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatusJeffrey M Rybak, Wenbo Ge, Nathan P Wiederhold, et al.
Nanomaterials (Basel, Switzerland)|July 2, 2021
The Influence of a Knitted Hydrophilic Prosthesis of Blood Vessels on the Activation of Coagulation System-In Vitro StudyMaria Szymonowicz, Maciej Dobrzynski, Sara Targonska, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2013
Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISAB J Werth, C Vidaillac, K P Murray, et al.
Molecular Pharmaceutics|December 4, 2013
Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabelingEszter Boros, Elena Rybak-Akimova, Jason P Holland, et al.
Antibiotics (Basel, Switzerland)|October 17, 2020
Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic ModelJacinda C Abdul-Mutakabbir, Razieh Kebriaei, Kyle C Stamper, et al.
Pageof 228